Blue Light Induces Retinal Ganglion Cell Damage by Stimulating Drp1-Dependent Mitochondrial Fission and Activating NF-κB/NOX4 Axis.
Level 5 - mechanism / opinion, no new human data
Preclinical in vitro and in vivo mechanistic laboratory study without human data.
PubMed 42171430 · doi:10.1167/iovs.67.5.62
What was done
Researchers evaluated the mechanisms underlying blue light-induced neurotoxicity in retinal ganglion cells (RGCs) using both in vitro and in vivo models. They analyzed molecular markers of mitochondrial dynamics (Drp1, MFN2), NF-κB signaling (p65), NOX4 expression, and mitochondrial reactive oxygen species (ROS) production, while assessing the effects of pharmacological inhibition of Drp1, p65, and NOX4 on mitochondrial function and RGC apoptosis.
What was found
The abstract does not report quantitative numerical data or effect sizes. Blue light exposure upregulated Drp1, downregulated MFN2, and stimulated mitochondrial fission. This activated nuclear translocation and phosphorylation of p65, which increased NOX4 transcription and mitochondrial ROS generation. Pharmacological inhibition of Drp1 or p65 suppressed NOX4 expression and ROS generation, and dual inhibition of Drp1 and NOX4 restored mitochondrial function and reduced RGC apoptosis.
Why it matters
The study outlines a specific Drp1/p65/NOX4 signaling pathway driving blue light-induced retinal phototoxicity, highlighting combined Drp1 and NOX4 inhibition as a candidate strategy for mitigating light-induced retinal injury.
Limits
The abstract does not provide exact sample sizes, exposure parameters (intensity, duration, specific wavelength), animal species, or quantitative measurements. As a preclinical mechanistic study, direct applicability to human clinical conditions and typical ambient light exposure remains unestablished.
Cited by
- supports Exposing cultured cells in vitro to blue light causes an increase in reactive oxygen species.